Latest Headlines

Latest Headlines

Canadian VC CTI unveils a $112M new biotech fund

CTI Life Sciences, a Montreal-headquartered biotech backer, has put together a $112 million new purse, scouting for promising startups in Canada and abroad.

Scientists identify virus triggering mass duck die-offs on Cape Cod

Scientists have uncovered a virus that has been causing yearly mass die-offs of eider ducks along Cape Cod, MA, since 1998.

Nova Scotia establishes program to support beef industry and safety standards

A new program funded by the government of Nova Scotia has been established with the purpose of supporting the growing beef industry in the Canadian province as well as improve animal production safety standards.

Natura Pet issues 8-state voluntary recall of cat food; Canada included

Natura Pet Products issued a voluntary recall of some of its EVO dry cat and dry ferret food, citing a formulation error that resulted in insufficient levels of vitamins and excess minerals.

Baxter spends $10M expanding admixing facility in Canada

Baxter International will spend $10 million to expand its pharma admixing capacity in Canada.

Canadian government funds Elanco genomics project

The Canadian government is pouring $56 million into 12 projects aimed at translating genomic discoveries into marketable products, including several in the animal health industry. The initiative aims to link up academic institutions with users of genomic research, including drug companies, nonprofit agencies, and government bodies.

Apotex tries to 'set the record straight' after Health Canada quarantine request

The three-way spat between Health Canada, local media and Apotex is rumbling on. Late last week Health Canada won an equivocal thumbs-up from the media for its move to quarantine products from one of Apotex's Indian plants, only for the generic drugmaker to hit back with a press release to "set the record straight."

Out with the new and in with the old after GSK trips up at vaccine plant

Problems with a new manufacturing process at the GlaxoSmithKline influenza vaccine plant in Canada caused some of the issues raised by regulators there, and so the U.K. drugmaker is reverting to its earlier process to get product to the market for the upcoming flu season.

Health Canada gives GSK 30 days to show how it will fix its vaccine plant

Having spent the past few months trying to bring standards at its Quebec City vaccine plant in line with FDA expectations, GlaxoSmithKline must now work to satisfy another regulator: Health Canada. The Canadian regulator sent GSK an inspection report late last week and gave the Big Pharma 30 days to come up with a plan to fix the problems faced by the facility.

Canada to implement UDI based solely on international guidelines

Canada will follow the International Medical Device Regulators Forum unique device identification guidelines to the "T" as it works toward the national implementation of the tracking system. Mass Device reports that federal regulator Health Canada has no plans to add any Canada-specific guidelines at this time.